Tisotumab vedotin for treating recurrent or metastatic cervical cancer after chemotherapy [ID3753]

  • In development
  • GID-TA10620
  • Expected publication date: 

Documents

Documents created during the development process.

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 3753